62 unknown. 62 Phase 3, 12 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 62 | Unknown 62 |
| Phase 2 | 12 | Unknown 12 |
Follow Neoplasms, Nerve Tissue: new trials by email Literature Review of Neoplasms, Nerve Tissue trials Research Report on Neoplasms, Nerve Tissue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma BCD-201, Keytruda - Melanoma (Skin) | Phase 3 | Unknown | Biocad | 366 | 2022-07-18 | 2023-09-21 |
| Prolgolimab 250 mg Q3W in Patients With Unresectable or Metastatic Melanoma Prolgolimab - Unresectable or Metastatic Melanoma | Phase 3 | Unknown | Biocad | 114 | 2022-02-01 | 2023-03-24 |
| Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children Nimotuzumab+CRT(concurrent IMRT and TMZ) - Diffuse Intrinsic Pontine Glioma | Phase 3 | Unknown | Biotech Pharmaceutical Co., Ltd. | 48 | 2021-04-03 | 2023-07-27 |
| Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma Temozolomide - Glioblastoma | Phase 3 | Unknown | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 80 | 2020-11-01 | 2021-04-02 |
| Proton and Heavy Ion Beam Radiation vs. Photon Beam Radiation for Newly Diagnosed Glioblastoma. Radiotherapy - Glioblastoma | Phase 3 | Unknown | Shanghai Proton and Heavy Ion Center | 369 | 2020-10-01 | 2020-09-02 |
| Vitamin D3 in Sensory Recovery After Digital NERVe Suture (D3NERV). Cholecalciferol, Placebos - Digital Nerve Injury | Phase 3 | Unknown | University Hospital, Caen | 72 | 2020-01-20 | 2021-08-31 |
| 68Ga-DOTA-TATE PET/CT Imaging in NETs 68Ga-DOTA-TATE - Neuroendocrine Tumors | Phase 3 | Unknown | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | 5000 | 2020-01-01 | 2024-07-18 |
| ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM) Autologous Dendritic Cell/Tumor Antigen, ADCTA - Glioblastoma Multiforme | Phase 3 | Unknown | Safe Save Medical Cell Sciences & Technology Co.,Ltd. | 118 | 2019-09-19 | 2020-03-17 |
| Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma Simmtecan, 5-FU and l-LV, Toripalimab, Etoposide, Cisplatin - Neuroendocrine Carcinoma of the Bladder | Phase 2 / Phase 3 | Unknown | Peking University | 336 | 2019-06-19 | 2019-06-20 |
| Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM CCRT, Temozolomide, Siroquine - Glioblastoma | Phase 2 / Phase 3 | Unknown | Johnpro Biotech, Inc. | 288 | 2018-10-11 | 2021-05-11 |
| A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme Sunitinib, Lomustine - Glioblastoma Multiforme, Glioblastoma, Adult | Phase 2 / Phase 3 | Unknown | Amsterdam UMC, location VUmc | 100 | 2018-08-31 | 2021-04-19 |
| International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013) Temozolomide + Valproic Acid - Glioblastoma WHO Grade IV, Diffuse Midline Glioma Histone 3 K27M WHO Grade IV | Phase 3 | Unknown | University of Göttingen | 167 | 2018-07-17 | 2022-06-06 |
| Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy Dendritic cell immunization, Adjuvant temozolomide - Glioblastoma | Phase 2 / Phase 3 | Unknown | Oslo University Hospital | 60 | 2018-04-26 | 2024-04-03 |
| Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma Temozolomide - Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain | Phase 3 | Unknown | Mashhad University of Medical Sciences | 62 | 2018-03-03 | 2018-08-16 |
| MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients Propranolol, Placebo - Melanoma | Phase 2 / Phase 3 | Unknown | Azienda Sanitaria di Firenze | 546 | 2017-06-01 | 2016-11-15 |
| Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy postoperative adjuvant RT - Glioma of Brain | Phase 2 / Phase 3 | Unknown | Chang Gung Memorial Hospital | 80 | 2016-08-01 | 2023-05-01 |
| M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma M-Vax- autologous, hapten-modified melanoma vaccine - Melanoma | Phase 3 | Unknown | AVAX Technologies | 387 | 2016-07-01 | 2015-12-03 |
| Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients Eflornithine, Lomustine - Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma | Phase 3 | Unknown | Orbus Therapeutics, Inc. | 343 | 2016-07-01 | 2022-01-21 |
| A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme Temozolomide - Anaplastic Oligoastrocytoma, Glioblastoma | Phase 3 | Unknown | Sun Yat-sen University | 78 | 2015-11-08 | 2022-10-31 |
| A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas β-elemene - Anaplastic Oligoastrocytoma, Anaplastic Astrocytoma | Phase 3 | Unknown | Sun Yat-sen University | 100 | 2015-04-01 | 2018-02-23 |
Showing 20 of 62. Sign in to see all of them.
Melanoma (18) · Glioblastoma (16) · Astrocytoma (11) · Glioma (9) · Brain Neoplasms (7) · Neuroblastoma (7) · Central Nervous System Neoplasms (4) · Oligodendroglioma (4) · Neoplasm Metastasis (3) · Diffuse Intrinsic Pontine Glioma (2) · Meningioma (2) · Neoplasms (2) · Neuroectodermal Tumors, Primitive, Peripheral (2) · Retinoblastoma (2) · Sarcoma (2)
Neoplasms by Histologic Type (62) · Neoplasms (60) · Neoplasms, Germ Cell and Embryonal (60) · Neuroectodermal Tumors (60) · Neoplasms, Glandular and Epithelial (39) · Neoplasms, Neuroepithelial (37) · Neoplasms by Site (34) · Neuroendocrine Tumors (22) · Nevi and Melanomas (19) · Glioma (18) · Skin Diseases (18) · Skin Neoplasms (18) · Skin and Connective Tissue Diseases (18) · Nervous System Diseases (14)
Vincristine (13) · Radiotherapy (11) · Carboplatin (10) · Etoposide (10) · Temozolomide (10) · Cyclophosphamide (8) · Cisplatin (7) · Doxorubicin (5) · Melphalan (5) · Busulfan (4) · Chemotherapy, Adjuvant (4) · Filgrastim (4) · Ifosfamide (4) · Lomustine (4) · Peripheral Blood Stem Cell Transplantation (4)
Sun Yat-sen University (6) · Children's Cancer and Leukaemia Group (3) · European Organisation for Research and Treatment of Cancer - EORTC (3) · Biocad (2) · CancerVax Corporation (2) · German Society for Pediatric Oncology and Hematology GPOH gGmbH (2) · University of Leicester (2) · AVAX Technologies (1) · Amsterdam UMC, location VUmc (1) · Assistance Publique - Hôpitaux de Paris (1) · Azienda Sanitaria di Firenze (1) · Biotech Pharmaceutical Co., Ltd. (1) · Centre de recherche du Centre hospitalier universitaire de Sherbrooke (1) · Centro Oncologico de Excelencia (1) · Chang Gung Memorial Hospital (1)
Germany (13) · United Kingdom (13) · China (12) · Canada (10) · France (10) · United States (10) · Italy (9) · Switzerland (9) · Netherlands (8) · Australia (7) · Israel (7) · Belgium (6) · Austria (5) · Ireland (5) · Portugal (5)
Alexander M. M. Eggermont, MD, PhD (3) · Alan W. Craft, MD (2) · Ann Barrett (2) · Heribert F. Juergens, MD (2) · Huasheng Yang, Doctor (2) · Ruth Ladenstein, MD (2) · Andrew David J. Pearson, MD, FRCP, DCh (1) · Andrey S. Bryukhovetskiy, MD (1) · Christof Kramm, Prof., MD (1) · Christoph Kramm, MD (1) · Daniel Worsley, MD (1) · David A. Walker (1) · Douglas Hawkins, MD (1) · Frank Berthold, MD (1)
PMID 20567002, PMID 32691060, PMID 11745440, PMID 16198768, PMID 16572419, PMID 17159027, PMID 17337065, PMID 17620582, PMID 18620949, PMID 18802150, PMID 19118701, PMID 19433686, PMID 19621225, PMID 19760772, PMID 19793643, PMID 20308673, PMID 20385998, PMID 20547982, PMID 20694800, PMID 21087856, PMID 21546857, PMID 21600759, PMID 21715171, PMID 22202581, PMID 22742881, PMID 23545055, PMID 23817721, PMID 24590653, PMID 24982464, PMID 25303679, PMID 25789053, PMID 26503196, PMID 27465021, PMID 28259608, PMID 28570730, PMID 28620382, PMID 29019177, PMID 29120699, PMID 29610659, PMID 29755120, PMID 29774030, PMID 29843811, PMID 30015396, PMID 30442501, PMID 31553693, PMID 32013055, PMID 32639845, PMID 33235996, PMID 34115544, PMID 35343323
2018 (1)